MG-101 has beenconsidered as a drug to support colon cancer prevention,43 and the comparably small hydrophobic leucineside chains may contribute to the beneficial inhibition of a numberof related cysteine proteases in this context. The gene discussed is CTSB; the disease is malignant colon neoplasm.